Safety Experience During Real-World Use of Injectable Artesunate in Public Health Facilities in Ghana and Uganda: Outcomes of a Modified Cohort Event Monitoring Study (CEMISA)

ConclusionThe incidence of common AEs among patients treated with Inj AS in real-world settings was found to be relatively low. Future studies should consider larger cohorts to document rare AEs as well.ClinicalTrials.gov IdentifierNCT02817919.
Source: Drug Safety - Category: Drugs & Pharmacology Source Type: research